Abstract
Oncology rehabilitation is an expanding field of medical care focused on preparing the cancer patient for upcoming cancer treatment (prehabilitation); maintaining patient strength, functioning and quality of life during cancer treatment; and helping patients either recover strength, functioning, and quality of life following cancer treatment or adjust to the long-term sequelae associated with their cancer or cancer-related treatments. This chapter addresses how rehabilitation interventions (1) fit into the continuum of cancer care; (2) can be used to address cancer and cancer treatment-related side effects such as pain, fatigue, lymphedema, cognitive dysfunction, and bone issues; and (3) can be used in cases of specific cancer diagnoses including, but not limited to breast, lung, prostate, colorectal, head and neck, and hematologic cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIMSS:
-
Aromatase inhibitor-induced musculoskeletal symptoms
- ALL:
-
Acute lymphoblastic leukemia
- ALND:
-
Axillary lymph node dissection
- AML:
-
Acute myeloid leukemia
- CDT:
-
Complete decongestive therapy
- CIPN:
-
Chemotherapy-induced peripheral neuropathy
- CLL:
-
Chronic lymphocytic leukemia
- CML:
-
Chronic myeloid leukemia
- CoC:
-
Commission on Cancer
- COPD:
-
Chronic obstructive pulmonary disease
- CT:
-
Computed tomography
- ES:
-
Ewing’s sarcoma
- FVC:
-
Forced vital capacity
- GVHD:
-
Graft-versus-host disease
- HH:
-
Home health agencies
- HL:
-
Hodgkin’s lymphoma
- ICF:
-
International Classification of Functioning, Disability and Health
- ICU:
-
Intensive care unit
- IRF:
-
Inpatient rehabilitation facilities
- LOS:
-
Length of stays
- LTAC:
-
Long-term acute care hospitals
- LTCH:
-
Long-term care hospitals
- MCI:
-
Mild cognitive impairment
- MM:
-
Multiple myeloma
- MRI:
-
Magnetic resonance imaging
- NAPBC:
-
National Accreditation Program for Breast Centers
- NCI:
-
National Cancer Institute
- NCMMR:
-
National Center for Medical Rehabilitation Research
- NHL:
-
Non-Hodgkin’s lymphoma
- NIH:
-
National Institutes of Health
- NSCLC:
-
Non-small cell lung carcinoma
- OT:
-
Occupational therapy
- PAC:
-
Post-acute care
- PSA:
-
Prostate-specific antigen
- PT:
-
Physical therapists
- QOL:
-
Quality of life
- RT:
-
Radiation therapy
- SCT:
-
Stem cell transplantation
- SLNB:
-
Sentinel lymph node biopsy
- SLP:
-
Speech and language pathology services
- SNF:
-
Skilled nursing facilities
- SNRIs:
-
Serotonin and norepinephrine reuptake inhibitors
- TKI:
-
Tyrosine kinase inhibitors
- TNS:
-
Transcutaneous nerve stimulation
- WHO:
-
World Health Organization
References
Silver JK, Raj VS, Fu JB, Wisotzky EM, Smith SR, Kirch RA. Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services. Support Care Cancer. 2015;23:3633–43.
Silver JK, Baima J, Mayer RS. Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin. 2013;63:295–317.
Silver JK, Raj VS, Fu JB, Wisotzky EM, Smith SR, Knowlton SE, et al. Most national cancer institute-designated cancer center websites do not provide survivors with information about cancer rehabilitation services. J Cancer Educ. 2017. https://www-ncbi-nlm-nih-gov.ezp-prod1.hul.harvard.edu/pubmed/28064402. Accessed 20 June 2017.
Stout NL, Silver JK, Raj VS, Rowland J, Gerber L, Cheville A, et al. Toward a national initiative in cancer rehabilitation: recommendations from a subject matter expert group. Arch Phys Med Rehabil. 2016;97:2006–15.
Broadwell DC. Rehabilitation needs of the patient with cancer. Cancer. 1987;60:563–8.
Driessen EJ, Peeters ME, Bongers BC, Maas HA, Bootsma GP, van Meeteren NL, et al. Effects of prehabilitation and rehabilitation including a home-based component on physical fitness, adherence, treatment tolerance, and recovery in patients with non-small cell lung cancer: a systematic review. Crit Rev Oncol Hematol. 2017;114:63–76.
Onerup A, Angenete E, Bock D, Borjesson M, Fagevik Olsen M, Gryback Gillheimer E, et al. The effect of pre- and post-operative physical activity on recovery after colorectal cancer surgery (physsurg-c): study protocol for a randomised controlled trial. Trials. 2017;18:212.
Minnella EM, Bousquet-Dion G, Awasthi R, Scheede-Bergdahl C, Carli F. Multimodal prehabilitation improves functional capacity before and after colorectal surgery for cancer: a five-year research experience. Acta Oncol. 2017;56:295–300.
Carli F, Gillis C, Scheede-Bergdahl C. Promoting a culture of prehabilitation for the surgical cancer patient. Acta Oncol. 2017;56:128–33.
Masley PM, Havrilko CL, Mahnensmith MR, Aubert M, Jette DU. Physical therapist practice in the acute care setting: a qualitative study. Phys Ther. 2011;91:906–19.
Smith BA, Fields CJ, Fernandez N. Physical therapists make accurate and appropriate discharge recommendations for patients who are acutely ill. Phys Ther. 2010;90:693–703.
Malone D, Ridgeway K, Nordon-Craft A, Moss P, Schenkman M, Moss M. Physical therapist practice in the intensive care unit: results of a national survey. Phys Ther. 2015;95:1335–44.
Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009;37:2499–505.
Mechanic R. Post-acute care--the next frontier for controlling medicare spending. N Engl J Med. 2014;370:692–4.
Inpatient rehabilitation therapy services: Complying with documentation requirements. Department Of Health and Human Services, Centers for Medicare & Medicaid Services. 2012. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/inpatient_rehab_fact_sheet_icn905643.pdf. Accessed 30 Apr 2017.
Shay PD, Ozcan YA. Freestanding inpatient rehabilitation facility performance following the 60 percent rule: a matter of fit. Med Care Res Rev. 2013;70:46–67.
Inpatient rehabilitation facility prospective payment system. Department of Health and Human Services, Center for Medicare & Medicaid Services. 2017. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/InpatRehabPaymtfctsht09-508.pdf. Accessed 30 April 2017.
Goldberg TH. The long-term and post-acute care continuum. W V Med J. 2016;112:68–74.
Coverage of extended care (snf) services under hospital insurance. Medicare Benefit Policy Manual. Rev 228, 10–13-16. Centers for Medicare & Medicaid Services. 2016. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bp102c08.pdf. Accessed 24 April 2017.
Eskildsen MA. Long-term acute care: a review of the literature. J Am Geriatr Soc. 2007;55:775–9.
Kahn JM, Werner RM, David G, Ten Have TR, Benson NM, Asch DA. Effectiveness of long-term acute care hospitalization in elderly patients with chronic critical illness. Med Care. 2013;51:4–10.
Long term care hospital prospective payment system. Department Of Health and Human Services, Centers for Medicare & Medicaid Services. 2016. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/Downloads/Long-Term-Care-Hospital-PPS-Fact-Sheet-ICN006956.pdf. Accessed 28 April 2017.
Ellenbecker CH, Samia L, Cushman MJ, Alster K. Patient safety and quality in home health care. In: Hughes R, editor. Patient safety and quality: an evidence-based handbook for nurses. Rockville, MD: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; 2008. https://archive.ahrq.gov/professionals/clinicians-providers/resources/nursing/resources/nurseshdbk/nurseshdbk.pdf. Accessed 12 Jun 2017.
U.S. Centers for Medicare & Medicaid Services. Your medicare coverage - home health services. https://www.medicare.gov/coverage/home-health-services.html. Accessed 26 April 2017.
U.S. Centers for Medicare & Medicaid Services. Outpatient rehabilitation providers. 2013. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/CertificationandComplianc/OutpatientRehab.html. Accessed 1 May 2017.
U.S. Centers for Medicare & Medicaid Services. Your medicare coverage - physical therapy/occupational therapy/speech-language pathology services. https://www.medicare.gov/coverage/pt-and-ot-and-speech-language-pathology.html. Accessed 1 May 2017.
U.S. Centers for Medicare & Medicaid Services. Medicare limits on therapy services. 2017. https://www.medicare.gov/Pubs/pdf/10988-Medicare-Limits-Therapy-Services.pdf. Accessed 1 May 2017.
Silver JK. Cancer rehabilitation and prehabilitation may reduce disability and early retirement. Cancer. 2014;120:2072–6.
Silver J, Mayer RS. Barriers to pain management in the rehabilitation of the surgical oncology patient. J Surg Oncol. 2007;95:427–35.
Cancer pain relief: With a guide to opioid availability. 2nd ed. Geneva, Switzerland: World Health Organization; 1996.
Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med. 1983;45:333–9.
Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 rcts. Cancer Treat Rev. 2017;52:91–104.
Carli F, Silver JK, Feldman LS, McKee A, Gilman S, Gillis C, et al. Surgical prehabilitation in patients with cancer: state-of-the-science and recommendations for future research from a panel of subject matter experts. Phys Med Rehabil Clin N Am. 2017;28:49–64.
Stigt JA, Uil SM, van Riesen SJ, Simons FJ, Denekamp M, Shahin GM, et al. A randomized controlled trial of postthoracotomy pulmonary rehabilitation in patients with resectable lung cancer. J Thorac Oncol. 2013;8:214–21.
Streckmann F, Zopf EM, Lehmann HC, May K, Rizza J, Zimmer P, et al. Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med. 2014;44:1289–304.
Takamura Y, Miyauchi A, Tomoda C, Uruno T, Ito Y, Miya A, et al. Stretching exercises to reduce symptoms of postoperative neck discomfort after thyroid surgery: prospective randomized study. World J Surg. 2005;29:775–9.
McNeely ML, Parliament M, Courneya KS, Seikaly H, Jha N, Scrimger R, et al. A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck. 2004;26:518–30.
Hase K, Kamisako M, Fujiwara T, Tsuji T, Liu M. The effect of zaltoprofen on physiotherapy for limited shoulder movement in breast cancer patients: a single-blinded before-after trial. Arch Phys Med Rehabil. 2006;87:1618–22.
Searle RD, Bennett MI, Johnson MI, Callin S, Radford H. Transcutaneous electrical nerve stimulation (tens) for cancer bone pain. J Pain Symptom Manag. 2009;37:424–8.
Cristian A, Tran A, Patel K. Patient safety in cancer rehabilitation. Phys Med Rehabil Clin N Am. 2012;23:441–56.
Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34:3325–45.
Grunfeld EA, Cooper AF. A longitudinal qualitative study of the experience of working following treatment for gynaecological cancer. Psychooncology. 2012;21:82–9.
Nccn clinical practice guidelines in oncology: Cancer-related fatigue. Version 1.2009. Rockledge, PA: National Comprehensive Cancer Network; 2009.
Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer. 2001;92:1689–93.
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 1994;121:953–9.
Gerber LH. Cancer-related fatigue: persistent, pervasive, and problematic. Phys Med Rehabil Clin N Am. 2017;28:65–88.
Juvet LK, Thune I, Elvsaas IKO, Fors EA, Lundgren S, Bertheussen G, et al. The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis. Breast. 2017;33:166–77.
Twomey R, Aboodarda SJ, Kruger R, Culos-Reed SN, Temesi J, Millet GY. Neuromuscular fatigue during exercise: methodological considerations, etiology and potential role in chronic fatigue. Neurophysiol Clin. 2017;47:95–110.
Keilani M, Hasenoehrl T, Baumann L, Ristl R, Schwarz M, Marhold M, et al. Effects of resistance exercise in prostate cancer patients: a meta-analysis. Support Care Cancer. 2017 Sep;25(9):2953–68.
Miller CL, Specht MC, Skolny MN, Horick N, Jammallo LS, O'Toole J, et al. Risk of lymphedema after mastectomy: potential benefit of applying acosog z0011 protocol to mastectomy patients. Breast Cancer Res Treat. 2014;144:71–7.
Jensen MR, Simonsen L, Karlsmark T, Bulow J. Lymphoedema of the lower extremities--background, pathophysiology and diagnostic considerations. Clin Physiol Funct Imaging. 2010;30:389–98.
NABPC Standards Manual. 2014 ed. Chicago, IL: American College of Surgeons; 2014.
Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.
Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003;13:214–25.
Stout NL, Pfalzer LA, Springer B, Levy E, McGarvey CL, Danoff JV, et al. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92:152–63.
Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34:691–8.
Cemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg. 2011;213:543–51.
Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361:664–73.
Bergo E, Lombardi G, Pambuku A, Della Puppa A, Bellu L, D'Avella D, et al. Cognitive rehabilitation in patients with gliomas and other brain tumors: state of the art. Biomed Res Int. 2016;2016:3041824.
Vargo M, Henriksson R, Salander P. Rehabilitation of patients with glioma. Handb Clin Neurol. 2016;134:287–304.
Haskins EC. Cognitive rehabilitation manual: translating evidence-based recommendations into practice. 1st ed. Reston, VA: American Congress of Rehabilitation Medicine; 2012.
Bush SH, Kanji S, Pereira JL, Davis DH, Currow DC, Meagher DJ, et al. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manag. 2014;48:231–48.
Zimmer P, Baumann FT, Oberste M, Wright P, Garthe A, Schenk A, et al. Effects of exercise interventions and physical activity behavior on cancer related cognitive impairments: a systematic review. Biomed Res Int. 2016;2016:1820954.
Dai X, Ma W, He X, Jha RK. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and ewing's sarcoma. Med Sci Monit. 2011;17:RA177–90.
Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.
Tiwari A. Current concepts in surgical treatment of osteosarcoma. J Clin Ortho Trauma. 2012;3:4–9.
Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S. The role of radiotherapy in oseosarcoma. Cancer Treat Res. 2009;152:147–64.
Andreou D, Ruppin S, Fehlberg S, Pink D, Werner M, Tunn PU. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up. Acta Orthop. 2011;82:749–55.
Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320–9.
Rani PS, Shyamala K, Girish HC, Murgod S. Pathogenesis of Ewing sarcoma: a review. J Adv Clin Res Insights. 2015;2:164–8.
Ozaki T. Diagnosis and treatment of Ewing sarcoma of the bone: a review article. J Orthop Sci. 2015;20:250–63.
Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol. 2011;7:208–18.
Jawad MU, Scully SP. In brief: classifications in brief: Mirels' classification: metastatic disease in long bones and impending pathologic fracture. Clin Orthop Relat Res. 2010;468:2825–7.
Shapeero LG, Poffyn B, De Visschere PJ, Sys G, Uyttendaele D, Vanel D, et al. Complications of bone tumors after multimodal therapy. Eur J Radiol. 2011;77:51–67.
Fukumothi DK, Pupo H, Reganin LA, Matte SR, Lima BS, Mattos CA. Functional assessment of endoprosthesis in the treatment of bone tumors. Rev Bras Ortop. 2016;51:569–73.
Fauske L, Bruland OS, Grov EK, Bondevik H. Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities. Sarcoma. 2015;2015:484196.
Dieli-Conwright CM, Lee K, Kiwata JL. Reducing the risk of breast cancer recurrence: an evaluation of the effects and mechanisms of diet and exercise. Curr Breast Cancer Rep. 2016;8:139–50.
Wennman-Larsen A, Alexanderson K, Olsson M, Nilsson MI, Petersson LM. Sickness absence in relation to breast and arm symptoms shortly after breast cancer surgery. Breast. 2013;22:767–72.
Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, Gerwin RD, Goni AZ. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26:320–5.
Yang S, Park DH, Ahn SH, Kim J, Lee JW, Han JY, et al. Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment. Support Care Cancer. 2017;25:1317–22.
Crosbie J, Kilbreath SL, Dylke E, Refshauge KM, Nicholson LL, Beith JM, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90:679–92.
Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. PM R. 2014;6:170–83.
Wisotzky EM, Saini V, Kao C. Ultrasound-guided intercostobrachial nerve block for intercostobrachial neuralgia in breast cancer patients: a case series. PM R. 2016;8:273–7.
Zocca JA, Chen GH, Puttanniah VG, Hung JC, Gulati A. Ultrasound-guided serratus plane block for treatment of postmastectomy pain syndromes in breast cancer patients: a case series. Pain Pract. 2017;17:141–6.
Tang C, Eder S, Lee D, Rabow M, Esserman L. Abstract p3-10-03: a simple intervention to relieve chronic neuropathic post-mastectomy pain. Cancer Res 2013;73.
Kudlowitz D, Muggia F. Clinical features of taxane neuropathy. Anti-Cancer Drugs. 2014;25:495–501.
Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer. 2012;118:2250–60.
Gaillard S, Stearns V. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Breast Cancer Res. 2011;13:205.
Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol. 2007;25:3877–83.
Kirchgesner T, Larbi A, Omoumi P, Malghem J, Zamali N, Manelfe J, et al. Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine. 2014;81:485–92.
Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33:1104–11.
Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol. 2010;28:1154–60.
Henry NL, Banerjee M, Wicha M, Van Poznak C, Smerage JB, Schott AF, et al. Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. Cancer. 2011;117:5469–75.
Greenlee H, Crew KD, Shao T, Kranwinkel G, Kalinsky K, Maurer M, et al. Phase ii study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer. Support Care Cancer. 2013;21:1077–87.
Kubo M, Onishi H, Kuroki S, Okido M, Shimada K, Yokohata K, et al. Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer. Anticancer Res. 2012;32:2331–6.
Singer O, Cigler T, Moore AB, Levine AB, Do HT, Mandl LA. Hypovitaminosis d is a predictor of aromatase inhibitor musculoskeletal symptoms. Breast J. 2014;20:174–9.
Hung R, Krebs P, Coups EJ, Feinstein MB, Park BJ, Burkhalter J, et al. Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J Pain Symptom Manag. 2011;41:426–35.
Shannon VR. Role of pulmonary rehabilitation in the management of patients with lung cancer. Curr Opin Pulm Med. 2010;16:334–9.
Bayly JL, Lloyd-Williams M. Identifying functional impairment and rehabilitation needs in patients newly diagnosed with inoperable lung cancer: a structured literature review. Support Care Cancer. 2016;24:2359–79.
Cavalheri V, Granger C. Preoperative exercise training for patients with non-small cell lung cancer. Cochrane Database Syst Rev. 2017;6:CD012020.
Wang H, Liu X, Rice SJ, Belani CP. Pulmonary rehabilitation in lung cancer. PM R. 2016;8:990–6.
Edvardsen E, Skjonsberg OH, Holme I, Nordsletten L, Borchsenius F, Anderssen SA. High-intensity training following lung cancer surgery: a randomised controlled trial. Thorax. 2015;70:244–50.
Centers for Disease Control and Prevention. Cancer among men. 2016. https://www.cdc.gov/cancer/dcpc/data/men.htm. Accessed 18 June 2017.
Attard G, Parker C, Eeles RA, Schroder F, Tomlins SA, Tannock I, et al. Prostate cancer. Lancet. 2016;387:70–82.
Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin. 2008;58:196–213.
Simoneau AR. Treatment- and disease-related complications of prostate cancer. Rev Urol. 2006;8(Suppl 2):S56–67.
Chen RC, Hamstra DA, Sandler HM, Zietman AL. Complications of prostate cancer treatment. Lancet Oncol. 2014;15:e150.
Luo HC, Lei Y, Cheng HH, Fu ZC, Liao SG, Feng J, et al. Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy. Medicine. 2016;95:e3948.
Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366–78.
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–502.
Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3–27.
Schneider EC, Malin JL, Kahn KL, Ko CY, Adams J, Epstein AM. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer. 2007;110:2075–82.
Grosso G, Biondi A, Marventano S, Mistretta A, Calabrese G, Basile F. Major postoperative complications and survival for colon cancer elderly patients. BMC Surg. 2012;12(Suppl 1):S20.
Lange MM, Maas CP, Marijnen CA, Wiggers T, Rutten HJ, Kranenbarg EK, et al. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg. 2008;95:1020–8.
Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Cancer Netw. 2009;7:883–93; quiz 94
Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA. Risk of pelvic fractures in older women following pelvic irradiation. JAMA. 2005;294:2587–93.
Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, et al. Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J Clin Oncol. 2015;33:4085–92.
Henry M, Rosberger Z, Bertrand L, Klassen C, Hier M, Zeitouni A, et al. Suicidal ideations are prevalent in head and neck cancer patients and predate diagnosis: longitudinal study indicating the need for suicide prevention and collaborative care in ent clinics. Psychooncology. 2017;26:46.
Heckmann SM, Hujoel P, Habiger S, Friess W, Wichmann M, Heckmann JG, et al. Zinc gluconate in the treatment of dysgeusia--a randomized clinical trial. J Dent Res. 2005;84:35–8.
Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006;35:337–42.
Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer. Arch Phys Med Rehabil. 2010;91:1278–82.
National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer stat facts: Hodgkin lymphoma. https://seer.cancer.gov/statfacts/html/hodg.html. Accessed 18 June 2017.
Gobbi PG, Ferreri AJ, Ponzoni M, Levis A. Hodgkin lymphoma. Crit Rev Oncol Hematol. 2013;85:216–37.
Shankland KR, Armitage JO, Hancock BW. Non-hodgkin lymphoma. Lancet. 2012;380:848–57.
Zimmermann M, Oehler C, Mey U, Ghadjar P, Zwahlen DR. Radiotherapy for non-hodgkin's lymphoma: still standard practice and not an outdated treatment option. Radiat Oncol. 2016;11:110.
Ng AK, LaCasce A, Travis LB. Long-term complications of lymphoma and its treatment. J Clin Oncol. 2011;29:1885–92.
Zimmer P, Mierau A, Bloch W, Struder HK, Hulsdunker T, Schenk A, et al. Post-chemotherapy cognitive impairment in patients with b-cell non-hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leuk Lymphoma. 2015;56:347–52.
Fayette D, Gaherova L, Mocikova H, Markova J, Kozak T, Horacek J. Chemotherapy-related cognitive impairment in patients with hodgkin lymphoma - pathophysiology and risk factors. Klin Onkol. 2017;30:93–9.
Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943–55.
Saultz JN, Garzon R. Acute myeloid leukemia: a concise review. J Clin Med. 2016;5.
Nabhan C, Rosen ST. Chronic lymphocytic leukemia: a clinical review. JAMA. 2014;312:2265–76.
Apperley JF. Chronic myeloid leukaemia. Lancet. 2015;385:1447–59.
Baccarani M, Castagnetti F, Gugliotta G, Palandri F, Rosti G. Treatment recommendations for chronic myeloid leukemia. Mediterr J Hematol Infect Dis. 2014;6:e2014005.
Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89:731–8.
Kanellopoulos A, Andersson S, Zeller B, Tamnes CK, Fjell AM, Walhovd KB, et al. Neurocognitive outcome in very long-term survivors of childhood acute lymphoblastic leukemia after treatment with chemotherapy only. Pediatr Blood Cancer. 2016;63:133–8.
Ness KK, Hudson MM, Pui CH, Green DM, Krull KR, Huang TT, et al. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer. 2012;118:828–38.
Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91:101–19.
Al-Farsi K. Multiple myeloma: an update. Oman Med J. 2013;28:3–11.
Jaing TH. Complications of haematopoietic stem cell transplantation. ISBT Sci Ser. 2011;6:332–6.
de Souza CV, Miranda EC, Garcia C Jr, Aranha FJ, de Souza CA, Vigorito AC. Functional evaluation indicates physical losses after hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter. 2012;34:345–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Silver, J.K., Raj, V.S., Wisotzky, E.M. (2018). Oncology Rehabilitation. In: Hopewood, P., Milroy, M. (eds) Quality Cancer Care . Springer, Cham. https://doi.org/10.1007/978-3-319-78649-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-78649-0_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78648-3
Online ISBN: 978-3-319-78649-0
eBook Packages: MedicineMedicine (R0)